Simcha Therapeutics
PrivateLast Round
Series B
Jan 27, 2022
Total Funding Raised
$69.4M
Company Overview
Simcha Therapeutics is a biotechnology company developing cytokine immunotherapies that activate the immune system to combat diseases, especially cancers, through the development of decoy-resistant immunotherapies engineered via directed evolution.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simcha Therapeutics Comparables
Compare Simcha Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Peak Therapeutics | 89% | |
| Synthekine | 85% | |
| Suzhou Forlong Biotechnology Co., Ltd. | 79% | |
Simcha Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 27, 2022 | ||||
| Series A | Jun 24, 2020 | ||||
| Seed | Jul 5, 2018 |
Key People
Founding team and executive leadership
Simcha Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Series A |
| Logos Capital | Series B |
| ArrowMark Partners | Series B |
| BVF Partners L.P. | Series B |
| Pfizer | Series A |
| Samsara BioCapital | Series B |
| Rock Springs Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2022
$40M round led by SR One.
- Jun 24, 2020
$25M round led by HongShan.
Simcha Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Simcha Therapeutics's valuation, stock price, and market status.